Ligand validation:5NHD

XYP: beta-D-xylopyranose

XYP is a Ligand Of Interest in 5NHD designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5NHD_XYP_A_504	27%	54%	0.216	0.861	0.58	1.18	-	1	0	0	100%	1
5NHD_XYP_B_508	20%	61%	0.253	0.858	0.52	0.96	-	1	0	0	100%	1
5NHD_XYP_B_504	13%	56%	0.271	0.812	0.49	1.18	-	2	0	0	100%	1
5NHD_XYP_C_506	12%	60%	0.222	0.751	0.52	0.99	-	1	0	0	100%	1
5NHD_XYP_B_506	12%	39%	0.262	0.788	0.47	1.86	-	4	0	0	100%	1
5NHD_XYP_B_505	10%	23%	0.302	0.81	0.9	2.26	-	5	0	0	100%	1
5NHD_XYP_A_507	9%	29%	0.26	0.756	1.19	1.63	1	2	0	0	100%	1
5NHD_XYP_A_506	8%	68%	0.255	0.732	0.43	0.78	-	-	0	0	100%	1
5NHD_XYP_C_505	7%	22%	0.296	0.741	1.11	2.13	1	4	1	0	100%	1
5NHD_XYP_D_506	6%	50%	0.324	0.767	0.51	1.38	-	3	1	0	100%	1
5NH7_XYP_A_504	45%	53%	0.174	0.905	0.68	1.14	-	1	0	0	100%	1
5NH9_XYP_A_504	41%	54%	0.161	0.877	0.68	1.07	-	-	0	0	100%	1
5NH8_XYP_A_504	37%	61%	0.19	0.887	0.56	0.93	-	-	0	0	100%	1
5NHE_XYP_A_504	34%	55%	0.196	0.88	0.42	1.3	-	2	0	0	100%	1
1OD8_XYP_A_1311	100%	64%	0.047	0.992	0.75	0.64	-	-	0	0	100%	1
1V0M_XYP_A_1304	100%	71%	0.035	0.993	0.82	0.33	-	-	0	0	90%	0.9
2WYS_XYP_A_1001	99%	38%	0.052	0.983	0.69	1.7	-	4	3	0	100%	1
1V0N_XYP_A_1306	98%	60%	0.048	0.989	0.76	0.78	-	-	0	0	90%	0.9
1V0L_XYP_A_1305	98%	72%	0.055	0.992	0.52	0.57	-	-	0	0	90%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.